Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta‐mediated neurotoxicity
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is a common neurodegenerative, progressive, and fatal disorder. Generation and deposition of amyloid beta (Aβ) peptides associate with its pathogenesis and small soluble Aβ oligomers show the most pronounced neurotoxic effects and correlate with disease initiation and progression. Recent findings showed that Aβ oligomers bind to the cellular prion protein (PrP C ) eliciting neurotoxic effects. The role of exosomes, small extracellular vesicles of endosomal origin, in Alzheimer's disease is only poorly understood. Besides serving as disease biomarkers they may promote Aβ plaque formation, decrease Aβ‐mediated synaptotoxicity, and enhance Aβ clearance. Here, we explore how exosomal PrP C connects to protective functions attributed to exosomes in Alzheimer's disease. To achieve this, we generated a mouse neuroblastoma PrP C knockout cell line using transcription activator‐like effector nucleases. Using these, as well as SH‐SY5Y human neuroblastoma cells, we show that PrP C is highly enriched on exosomes and that exosomes bind amyloid beta via PrP C . Exosomes showed highest binding affinity for dimeric, pentameric, and oligomeric Aβ species. Thioflavin T assays revealed that exosomal PrP C accelerates fibrillization of amyloid beta, thereby reducing neurotoxic effects imparted by oligomeric Aβ. Our study provides further evidence for a protective role of exosomes in Aβ‐mediated neurodegeneration and highlights the importance of exosomal PrP C in molecular mechanisms of Alzheimer's disease. image We show that the prion protein (PrP C ) on exosomes captures neurotoxic species of amyloid beta (Aβ) promoting its fibrillization. Our study provides evidence for a protective role of exosomes in Alzheimer`s disease and suggests that, depending on its membrane topology, PrP C holds a dual function: when expressed at the neuronal surface it acts as receptor for Aβ leading to neurotoxic signaling, whereas it detoxifies Aβ when present on exosomes. This provides further support for key roles of PrP C in Alzheimer's disease. Read the Editorial Highlight for this article on page 9 . Cover Image for this issue: doi: 10.1111/jnc.13312 .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1×
“Small soluble oligomeric Ab peptides of 42 amino acids length (Ab42) are thought to represent the major neurotoxic entity causing synaptic dysfunction, dendritic spine loss, and ultimately neuronal death (Walsh et al. 2002; Lesne et al. 2006).”
BackgroundRetractedQuerfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Alzheimer’s disease β-amyloid peptides are released in association with exosomes
Rajendran, L., Honsho, M., Zahn, T. R., Keller, P., Geiger, K. D., Verkade, P., & Simons, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603838103 · Cited by 1,343
Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis
Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., Regen, T., Hanisch, U.-K., & Simons, M. (2011) · Journal of Cell Science · doi:10.1242/jcs.074088 · Cited by 866
Um, J. W., Kaufman, A. C., Kostylev, M., Heiss, J. K., Stagi, M., Takahashi, H., Kerrisk, M. E., Vortmeyer, A., Wisniewski, T., Koleske, A. J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.036 · Cited by 572
Dinkins, M. B., Dasgupta, S., Wang, G., Zhu, G., & Bieberich, E. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.012 · Cited by 494
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468 · cited 2×
“Nevertheless, exosomes devoid of PrP also showAb binding capacity, which may be attributed to glycosphingolipids (GSLs) or other suggested Ab binding partners (Renner et al. 2010).”
Background
Research works printed but not linked: 51
- 10.1103/PhysRevLett.111.232002 · doi:10.1103/physrevlett.111.232002
- 10.1186/1750-1326-6-36 · DOI
- 10.1111/febs.12196 · DOI
- 10.7554/eLife.04260 · DOI
- 10.1186/1756-6606-6-47 · DOI · Paper page
- 10.1194/jlr.R800007-JLR200 · DOI · Paper page
- 10.1523/JNEUROSCI.6500-10.2011 · DOI · Paper page
- 10.3389/fphys.2012.00124 · DOI · Paper page
- 10.1002/emmm.201000088 · DOI · Paper page
- 10.3402/jev.v1i0.18397 · DOI · Paper page
- 10.1016/S0002-9440(10)64572-5 · DOI
- 10.1093/nar/gkr218 · DOI · Paper page
- 10.1038/srep01921 · DOI
- 10.1186/1471-2202-11-130 · DOI · Paper page
- 10.1074/jbc.M110.208249 · DOI · Paper page
- 10.1186/1750-1326-7-42 · DOI · Paper page
- 10.1093/brain/awt375 · DOI · Paper page
- 10.1093/nar/gks608 · DOI · Paper page
- 10.1074/jbc.M112.423954 · DOI · Paper page
- 10.1038/ncomms1341 · DOI · Paper page
- 10.1523/JNEUROSCI.0395-10.2010 · DOI · Paper page
- 10.1080/19336896.2015.1065371 · DOI
- 10.1212/WNL.0000000000001702 · DOI · Paper page
- 10.1111/bpa.12166 · doi:10.1111/bpa.12166
- 10.1126/science.1072994 · DOI · Paper page
- 10.1038/cdd.2013.180 · DOI · Paper page
- 10.1007/s12035-013-8544-1 · DOI · Paper page
- 10.1038/22241 · DOI · Paper page
- 10.1523/JNEUROSCI.1858-12.2012 · DOI · Paper page
- 10.3892/mmr.2014.2484 · DOI · Paper page
- 10.1126/science.1178817 · DOI · Paper page
- 10.1074/jbc.C112.400614 · DOI
- 10.1111/jnc.12296 · DOI
- 10.1016/S0960-9822(01)00147-6 · DOI · Paper page
- 10.1016/0010-4655(82)90173-4 · DOI · Paper page
- 10.1002/jctb.2622 · DOI · Paper page
- 10.1038/emboj.2011.86 · DOI · Paper page
- 10.1159/000332596 · DOI
- 10.1074/jbc.M112.400358 · DOI · Paper page
- 10.1016/j.chembiol.2011.08.016 · DOI
- 10.1016/j.ceb.2009.03.007 · DOI · Paper page
- Simpson R. J., 2008, Quantifying protein by bicinchoninic Acid, CSH Protoc., 2008, Pdb prot4722
- 10.1016/j.ymeth.2012.01.002 · DOI · Paper page
- 10.1038/nn.3178 · DOI · Paper page
- 10.1007/s10719-008-9216-7 · DOI
- 10.1016/j.vetimm.2008.04.002 · DOI · Paper page
- 10.4161/pri.22588 · DOI
- 10.1096/fj.12-222588 · DOI · Paper page
- 10.1074/jbc.M111.324616 · DOI · Paper page
- 10.1074/jbc.M114.577213 · DOI · Paper page
- 10.1016/j.febslet.2014.11.027 · DOI · Paper page
Cited by
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
“Exosomesmay impair neurotoxic oligomer formation (133) or exosomes may carry themout of cells (134).”
BackgroundThe role of extracellular vesicles in neurodegenerative diseases
Quek, C., & Hill, A. F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.090 · Cited by 213
Laulagnier, K., Javalet, C., Hemming, F. J., Chivet, M., Lachenal, G., Blot, B., Chatellard, C., & Sadoul, R. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2664-0 · Cited by 164
Gomes, L. A., Hipp, S. A., Rijal Upadhaya, A., Balakrishnan, K., Ospitalieri, S., Koper, M. J., Largo-Barrientos, P., Uytterhoeven, V., Reichwald, J., Rabe, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02053-5 · Cited by 125
Astrocyte-derived extracellular vesicles: A double-edged sword in central nervous system disorders
Zhao, S., Sheng, S., Wang, Y., Ding, L., Xu, X., Xia, X., & Zheng, J. C. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.027 · Cited by 90
Amyloid-β: A double agent in Alzheimer's disease?
Yu, H., & Wu, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111575 · Cited by 62
Recent Advances on Extracellular Vesicles in Central Nervous System Diseases
Jin, T., Gu, J., Li, Z., Xu, Z., & Gui, Y. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s288415 · Cited by 44
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Sun, M., & Chen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466821 · Cited by 39
“64 Results indicate that NDEs may capture Aβ via GSLs and PrP(C) in a single or synergistic way, promoting Aβ aggregation and amyloid plaque formation.”
BackgroundThe emerging double-edged sword role of exosomes in Alzheimer’s disease
Liang, T., Wu, Z., Li, J., Wu, S., Shi, W., & Wang, L. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1209115 · Cited by 37
Small Extracellular Vesicles’ miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases
Lim, W. Q., Michelle Luk, K. H., Lee, K. Y., Nurul, N., Loh, S. J., Yeow, Z. X., Wong, Q. X., Daniel Looi, Q. H., Chong, P. P., How, C. W., et al. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041216 · Cited by 25
Muth, C., Schröck, K., Madore, C., Hartmann, K., Fanek, Z., Butovsky, O., Glatzel, M., & Krasemann, S. (2017) · Brain Pathology · doi:10.1111/bpa.12441 · Cited by 23
Self-citationInterlaminar and varicose-projection astrocytes: toward a new understanding of the primate brain
Ciani, C., & Falcone, C. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1477753 · Cited by 11
Metadata
- Authors
- Falker, C., Hartmann, A., Guett, I., Dohler, F., Altmeppen, H., Betzel, C., Schubert, R., Thurm, D., Wegwitz, F., Joshi, P., Verderio, C., Krasemann, S., & Glatzel, M.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2016-03-02
- Volume
- 137
- Issue
- 1
- Pages
- 88-100
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2294226441
- Cited by
- 165
- References
- 16
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Deutsche Forschungsgemeinschaft (GRK1459, SFB877)
- Seventh Framework Programme
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.